Skip to main content
Premium Trial:

Request an Annual Quote

Diagnostic Technology To Market Cepheid Systems in Australia, New Zealand

NEW YORK, June 12-The diagnostics distribution firm Diagnostic Technology will market Cepeheid's rapid quantitative PCR system in Australia and New Zealand, Cepheid said today.

 

Diagnostic Technology will provide marketing, sales and service support for the full line of Smart Cycler products, and will be the exclusive supplier of these Cepheid systems.

 

The Belrose, Australia-based company focuses on marketing products for the diagnosis of infectious disease.

 

The two companies did not reveal financial details of the agreement.

 

Cepheid is based in Sunnyvale, Calif.

The Scan

Team Tracks Down Potential Blood Plasma Markers Linked to Heart Failure in Atrial Fibrillation Patients

Researchers in BMC Genomics found 10 differentially expressed proteins or metabolites that marked atrial fibrillation with heart failure cases.

Study Points to Synonymous Mutation Effects on E. Coli Enzyme Activity

Researchers in Nature Chemistry saw signs of enzyme activity shifts in the presence of synonymous mutations in a multiscale modeling analysis of three Escherichia coli genes.

Team Outlines Paternal Sample-Free Single-Gene Approach for Non-Invasive Prenatal Screening

With data for nearly 9,200 pregnant individuals, researchers in Genetics in Medicine demonstrate the feasibility of their carrier screening and reflex single-gene non-invasive prenatal screening approach.

Germline-Targeting HIV Vaccine Shows Promise in Phase I Trial

A National Institutes of Health-led team reports in Science that a broadly neutralizing antibody HIV vaccine induced bnAb precursors in 97 percent of those given the vaccine.